186 related articles for article (PubMed ID: 3907315)
1. A comparison of the acute hemodynamic effects of prostacyclin and hydralazine in primary pulmonary hypertension.
Groves BM; Rubin LJ; Frosolono MF; Cato AE; Reeves JT
Am Heart J; 1985 Dec; 110(6):1200-4. PubMed ID: 3907315
[TBL] [Abstract][Full Text] [Related]
2. Hemodynamic effects of urapidil in patients with pulmonary hypertension. A comparative study with hydralazine.
Adnot S; Defouilloy C; Brun-Buisson C; Abrouk F; Piquet J; Lemaire F
Am Rev Respir Dis; 1987 Feb; 135(2):288-93. PubMed ID: 3813189
[TBL] [Abstract][Full Text] [Related]
3. Oral hydralazine therapy for primary pulmonary hypertension.
Rubin LJ; Peter RH
N Engl J Med; 1980 Jan; 302(2):69-73. PubMed ID: 7350435
[TBL] [Abstract][Full Text] [Related]
4. Comparative acute effects of adenosine and prostacyclin in primary pulmonary hypertension.
Nootens M; Schrader B; Kaufmann E; Vestal R; Long W; Rich S
Chest; 1995 Jan; 107(1):54-7. PubMed ID: 7813311
[TBL] [Abstract][Full Text] [Related]
5. Acute effect of hydralazine administration on pulmonary artery hemodynamics in dogs with chronic heartworm disease.
Atkins CE; Keene BW; McGuirk SM; Sato T
Am J Vet Res; 1994 Feb; 55(2):262-9. PubMed ID: 8172418
[TBL] [Abstract][Full Text] [Related]
6. Hemodynamic effects of nifedipine versus hydralazine in primary pulmonary hypertension.
Fisher J; Borer JS; Moses JW; Goldberg HL; Niarchos AP; Whitman HH; Mermelstein M
Am J Cardiol; 1984 Sep; 54(6):646-50. PubMed ID: 6475787
[TBL] [Abstract][Full Text] [Related]
7. [Vasodilator agents in pulmonary artery hypertension of systemic scleroderma].
Phlippoteau C; Brenot F; Blétry O; Simmonneau G; Duroux P
Rev Mal Respir; 1990; 7(3):249-54. PubMed ID: 2114030
[TBL] [Abstract][Full Text] [Related]
8. Hemodynamic effects of oxdralazine and hydralazine in hypertension.
Moskowitz RM; Cohn JN
Clin Pharmacol Ther; 1980 Jun; 27(6):773-8. PubMed ID: 7379444
[TBL] [Abstract][Full Text] [Related]
9. Pharmacologically induced pulmonary vasodilatation in children and young adults with primary pulmonary hypertension.
Barst RJ
Chest; 1986 Apr; 89(4):497-503. PubMed ID: 2869919
[TBL] [Abstract][Full Text] [Related]
10. Vasodilator therapy after heart transplantation: effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1, and sodium nitroprusside.
Kieler-Jensen N; Lundin S; Ricksten SE
J Heart Lung Transplant; 1995; 14(3):436-43. PubMed ID: 7654728
[TBL] [Abstract][Full Text] [Related]
11. Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension.
McLaughlin VV; Genthner DE; Panella MM; Rich S
N Engl J Med; 1998 Jan; 338(5):273-7. PubMed ID: 9445406
[TBL] [Abstract][Full Text] [Related]
12. Haemodynamic response to intravenous hydralazine in patients with pulmonary hypertension.
McGoon MD; Seward JB; Vlietstra RE; Choo MH; Moyer TP; Reeder GS
Br Heart J; 1983 Dec; 50(6):579-85. PubMed ID: 6652000
[TBL] [Abstract][Full Text] [Related]
13. Hemodynamic effects of vasodilators on pulmonary hypertension in decompensated chronic obstructive pulmonary disease.
Cerdá E; Esteban A; de la Cal MA; Fernández A; García A
Crit Care Med; 1985 Apr; 13(4):221-3. PubMed ID: 3979067
[TBL] [Abstract][Full Text] [Related]
14. Hemodynamic comparison of primary venous or arteriolar dilatation and the subsequent effect of furosemide in left ventricular failure after acute myocardial infarction.
Nelson GI; Silke B; Forsyth DR; Verma SP; Hussain M; Taylor SH
Am J Cardiol; 1983 Nov; 52(8):1036-40. PubMed ID: 6637819
[TBL] [Abstract][Full Text] [Related]
15. Hemodynamic profiles of prostaglandin E1, isoproterenol, prostacyclin, and nifedipine in experimental porcine pulmonary hypertension.
Prielipp RC; McLean R; Rosenthal MH; Pearl RG
Crit Care Med; 1991 Jan; 19(1):60-7. PubMed ID: 1986891
[TBL] [Abstract][Full Text] [Related]
16. Hemodynamics at rest and during exercise after oral hydralazine in patients with cor pulmonale.
Rubin LJ; Peter RH
Am J Cardiol; 1981 Jan; 47(1):116-22. PubMed ID: 7457397
[TBL] [Abstract][Full Text] [Related]
17. Comparative actions of hydralazine, nifedipine and amrinone in primary pulmonary hypertension.
Rich S; Ganz R; Levy PS
Am J Cardiol; 1983 Nov; 52(8):1104-7. PubMed ID: 6637831
[TBL] [Abstract][Full Text] [Related]
18. Hemodynamic effect of hydralazine in interstitial lung disease patients with cor pulmonale. Immediate and short-term evaluation at rest and during exercise.
Lupi-Herrera E; Seoane M; Verdejo J; Gomez A; Sandoval J; Barrios R; Martinez W
Chest; 1985 May; 87(5):564-73. PubMed ID: 3987368
[TBL] [Abstract][Full Text] [Related]
19. Hemodynamic effects of intravenous hydralazine in pregnant women with severe hypertension.
Kuzniar J; Skret A; Piela A; Szmigiel Z; Zaczek T
Obstet Gynecol; 1985 Oct; 66(4):453-8. PubMed ID: 4047535
[TBL] [Abstract][Full Text] [Related]
20. Acute hemodynamic effects of intravenous adenosine in patients with associated pulmonary arterial hypertension: Comparison with intravenous epoprostenol.
Rossi R; Coppi F; Sgura F; Monopoli D; Boriani G
Pulm Pharmacol Ther; 2018 Apr; 49():147-151. PubMed ID: 28642014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]